Arcellx IncNASDAQ:ACLX
- LAST PRICE53.2900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 53.2900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACLX |
|---|---|---|
| 09:32 ET | 5142 | 52.46 |
| 09:36 ET | 9500 | 52.31 |
| 09:38 ET | 200 | 51.8 |
| 09:39 ET | 100 | 52.4495 |
| 09:41 ET | 200 | 51.99 |
| 09:43 ET | 200 | 51.97 |
| 09:45 ET | 300 | 51.95 |
| 09:48 ET | 300 | 51.59 |
| 09:52 ET | 595 | 51.74 |
| 09:56 ET | 200 | 51.72 |
| 09:57 ET | 100 | 51.8 |
| 10:01 ET | 100 | 51.79 |
| 10:03 ET | 100 | 51.8 |
| 10:06 ET | 300 | 51.72 |
| 10:08 ET | 2250 | 51.795 |
| 10:10 ET | 300 | 51.52 |
| 10:12 ET | 100 | 51.69 |
| 10:14 ET | 2038 | 51.7 |
| 10:15 ET | 500 | 51.81 |
| 10:17 ET | 1000 | 51.62 |
| 10:19 ET | 716 | 51.68 |
| 10:21 ET | 400 | 51.6 |
| 10:24 ET | 200 | 51.81 |
| 10:28 ET | 400 | 51.745 |
| 10:30 ET | 1500 | 51.97 |
| 10:32 ET | 200 | 51.995 |
| 10:33 ET | 526 | 51.96 |
| 10:35 ET | 1568 | 52.33 |
| 10:37 ET | 200 | 52.195 |
| 10:39 ET | 688 | 52.3 |
| 10:42 ET | 744 | 52.565 |
| 10:44 ET | 200 | 52.475 |
| 10:48 ET | 400 | 52.69 |
| 10:50 ET | 300 | 52.8 |
| 10:53 ET | 3087 | 52.96 |
| 10:55 ET | 400 | 53.08 |
| 10:57 ET | 700 | 53.1 |
| 11:00 ET | 100 | 53.105 |
| 11:02 ET | 1000 | 53.15 |
| 11:04 ET | 100 | 53.045 |
| 11:06 ET | 100 | 53.06 |
| 11:08 ET | 500 | 52.97 |
| 11:09 ET | 100 | 53.12 |
| 11:11 ET | 800 | 53.26 |
| 11:13 ET | 1808 | 53.3 |
| 11:15 ET | 100 | 53.46 |
| 11:18 ET | 700 | 53.295 |
| 11:20 ET | 100 | 53.24 |
| 11:22 ET | 100 | 53.27 |
| 11:24 ET | 200 | 53.26 |
| 11:27 ET | 900 | 53.18 |
| 11:29 ET | 300 | 53.19 |
| 11:33 ET | 500 | 53.26 |
| 11:36 ET | 100 | 53.36 |
| 11:38 ET | 200 | 53.26 |
| 11:40 ET | 100 | 53.23 |
| 11:42 ET | 200 | 53.31 |
| 11:44 ET | 100 | 53.225 |
| 11:45 ET | 300 | 53.13 |
| 11:47 ET | 700 | 53.02 |
| 11:49 ET | 100 | 53.02 |
| 11:51 ET | 100 | 52.98 |
| 11:54 ET | 200 | 52.98 |
| 11:58 ET | 600 | 53.03 |
| 12:00 ET | 823 | 52.93 |
| 12:02 ET | 3599 | 52.97 |
| 12:03 ET | 800 | 53.11 |
| 12:05 ET | 900 | 53.08 |
| 12:07 ET | 700 | 53.08 |
| 12:09 ET | 2211 | 53.18 |
| 12:12 ET | 300 | 53.21 |
| 12:14 ET | 100 | 53.215 |
| 12:16 ET | 100 | 53.22 |
| 12:18 ET | 300 | 53.22 |
| 12:20 ET | 100 | 53.28 |
| 12:25 ET | 400 | 53.34 |
| 12:27 ET | 105 | 53.3045 |
| 12:30 ET | 200 | 53.23 |
| 12:32 ET | 400 | 53.235 |
| 12:34 ET | 500 | 53.3 |
| 12:36 ET | 1100 | 53.23 |
| 12:38 ET | 2000 | 53.29 |
| 12:41 ET | 200 | 53.2 |
| 12:43 ET | 100 | 53.11 |
| 12:45 ET | 1442 | 53.38 |
| 12:48 ET | 838 | 53.4525 |
| 12:52 ET | 100 | 53.445 |
| 12:54 ET | 300 | 53.445 |
| 12:59 ET | 100 | 53.56 |
| 01:01 ET | 200 | 53.53 |
| 01:08 ET | 1000 | 53.7 |
| 01:10 ET | 500 | 53.75 |
| 01:12 ET | 800 | 53.85 |
| 01:14 ET | 600 | 53.92 |
| 01:15 ET | 700 | 53.8 |
| 01:17 ET | 100 | 53.79 |
| 01:19 ET | 100 | 53.87 |
| 01:24 ET | 200 | 53.835 |
| 01:26 ET | 500 | 53.905 |
| 01:30 ET | 610 | 53.8949 |
| 01:32 ET | 100 | 53.94 |
| 01:33 ET | 126 | 53.89 |
| 01:35 ET | 700 | 53.985 |
| 01:37 ET | 300 | 54.05 |
| 01:39 ET | 300 | 53.905 |
| 01:42 ET | 100 | 53.8 |
| 01:44 ET | 835 | 53.805 |
| 01:48 ET | 200 | 53.8 |
| 01:50 ET | 7932 | 53.865 |
| 01:51 ET | 1868 | 53.69 |
| 01:53 ET | 500 | 53.58 |
| 01:55 ET | 233 | 53.535 |
| 02:00 ET | 700 | 53.62 |
| 02:04 ET | 100 | 53.69 |
| 02:06 ET | 7406 | 53.8425 |
| 02:08 ET | 100 | 53.825 |
| 02:11 ET | 300 | 53.83 |
| 02:18 ET | 811 | 53.57 |
| 02:24 ET | 205 | 53.61 |
| 02:26 ET | 100 | 53.59 |
| 02:27 ET | 171 | 53.63 |
| 02:29 ET | 611 | 53.56 |
| 02:33 ET | 600 | 53.6 |
| 02:36 ET | 400 | 53.585 |
| 02:42 ET | 100 | 53.55 |
| 02:44 ET | 300 | 53.48 |
| 02:49 ET | 2440 | 53.61 |
| 02:56 ET | 100 | 53.72 |
| 03:02 ET | 500 | 53.53 |
| 03:05 ET | 200 | 53.42 |
| 03:07 ET | 1330 | 53.57 |
| 03:09 ET | 100 | 53.64 |
| 03:14 ET | 1600 | 53.37 |
| 03:16 ET | 200 | 53.37 |
| 03:18 ET | 700 | 53.3 |
| 03:20 ET | 200 | 53.18 |
| 03:21 ET | 600 | 53.36 |
| 03:23 ET | 2524 | 53.31 |
| 03:25 ET | 800 | 53.56 |
| 03:27 ET | 100 | 53.59 |
| 03:30 ET | 200 | 53.54 |
| 03:32 ET | 300 | 53.55 |
| 03:34 ET | 606 | 53.615 |
| 03:36 ET | 3411 | 53.615 |
| 03:38 ET | 322 | 53.59 |
| 03:39 ET | 700 | 53.595 |
| 03:41 ET | 602 | 53.62 |
| 03:43 ET | 1350 | 53.65 |
| 03:45 ET | 1235 | 53.6 |
| 03:48 ET | 400 | 53.65 |
| 03:50 ET | 1056 | 53.7 |
| 03:52 ET | 3730 | 53.655 |
| 03:54 ET | 4400 | 53.44 |
| 03:56 ET | 2967 | 53.385 |
| 03:57 ET | 2558 | 53.29 |
| 03:59 ET | 52963 | 53.29 |
Apr 11, 2024
DJ Arcellx Price Target Maintained With a $81.00/Share by Needham, from 6:23AM ET on Thursday Apr 11, 2024 by Dow Jones
6:23AM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 4, 2024
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference, from 4:00PM ET on Thursday Apr 04, 2024 by Dow Jones
4:00PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Arcellx Inc | 2.8B | -35.8x | --- |
Merus NV | 2.8B | -15.9x | --- |
Rhythm Pharmaceuticals Inc | 2.5B | -12.9x | --- |
Summit Therapeutics Inc | 2.9B | -2.6x | --- |
NewAmsterdam Pharma Company NV | 2.0B | -8.3x | --- |
Apogee Therapeutics Inc | 2.9B | -30.0x | --- |
Company Information
Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).
Contact Information
- Headquarters
- 800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
- Phone
- 240-327-0603
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rami Elghandour
- Chief Financial Officer
- Michelle Gilson
- Chief Medical Officer
- Christopher Heery
- Chief Commercial Officer
- Neeraj Teotia
- Independent Director
- Ali Behbahani
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.8B |
|---|---|
Revenue (TTM) | $110.3M |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.49 |
Book Value | $9.28 |
P/E Ratio | -35.8x |
Price/Sales (TTM) | 25.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -81.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
